The Maxxon, Inc. ReVac Safety Syringe Activation Force Lab Study Completed And Design Work Finalized; The Manufacturing Of 5000 Piece Samples For FDA Application Process And Customer Evaluation Started

MOUNT PLEASANT, S.C., June 15 /PRNewswire-FirstCall/ -- Maxxon, Inc. (OTC Pink Sheets: MXON - News; “Maxxon”), a growing medical products designer, manufacturer, and distributor concentrating on innovative Safety-engineered medical devices (SEMDs) that will have a price advantage over many competitors in the SEMDs arena, announces the results of Globe Med Tech’s (“GMT”) optimum retraction activation force user/lab study for its Maxxon 3 cc Vacuum Operated Retractable Safety Syringe (“ReVac”) plunger.